Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Recruiting 5Active not recruiting 5Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1870Neoplasms 1254Colorectal Neoplasms 1057Carcinoma, Non-Small-Cell Lung 1012Stomach Neoplasms 801Carcinoma, Hepatocellular 784Lung Neoplasms 768Prostatic Neoplasms 697Pancreatic Neoplasms 578Rectal Neoplasms 447Ovarian Neoplasms 406Colonic Neoplasms 405Uterine Cervical Neoplasms 400Neoplasm Metastasis 400Recurrence 380Leukemia, Myeloid, Acute 372Esophageal Neoplasms 363Multiple Myeloma 339Lymphoma 335Head and Neck Neoplasms 329Melanoma 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Brain Neoplasms 263Urinary Bladder Neoplasms 254Liver Neoplasms 225Nasopharyngeal Carcinoma 223Leukemia 218Lymphoma, Large B-Cell, Diffuse 215Polycystic Ovary Syndrome 210Squamous Cell Carcinoma of Head and Neck 204

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma, Clear Cell × Clear all
NCT00226798 2006-01-04

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Rambam Health Care Campus

Phase 2 Unknown
45 enrolled

Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡